Use of Digital Health and Digital Therapeutics to Treat SUD in Criminal Justice Settings: a Review.

IF 4.1 2区医学 Q1 SUBSTANCE ABUSE Current Addiction Reports Pub Date : 2024-02-01 Epub Date: 2023-12-27 DOI:10.1007/s40429-023-00523-1

Ginnie Sawyer-Morris, Judith A Wilde, Todd Molfenter, Faye Taxman

{"title":"Use of Digital Health and Digital Therapeutics to Treat SUD in Criminal Justice Settings: a Review.","authors":"Ginnie Sawyer-Morris, Judith A Wilde, Todd Molfenter, Faye Taxman","doi":"10.1007/s40429-023-00523-1","DOIUrl":null,"url":null,"abstract":"Purpose of review: The purpose of this review is to investigate the use of digital health technologies and/or digital therapeutics (DTx) products in the treatment of substance use disorders (SUDs) in the general population and among criminal justice-involved individuals.Recent findings: Despite an expanding evidence base, only three SUD DTxs have received federal regulatory approval. Across studies, DTx products have proven successful in engaging patients in SUD treatment and reducing healthcare costs and resource utilizations. Findings for emerging SUD DTx products show similar results. Still, there is a paucity of evidence regarding the use of digital health technologies and/or DTx among criminal justice populations.Summary: DTxs have proven effective for treating multiple SUD types (e.g., nicotine and opioids) among the general population. DTx shows similar promise among justice-involved populations, but additional efficacy and implementation research is needed to address barriers such as cost, cultural resistance, and infrastructure.","PeriodicalId":52300,"journal":{"name":"Current Addiction Reports","volume":"11 1","pages":"149-162"},"PeriodicalIF":4.1000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11643629/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Addiction Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40429-023-00523-1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: The purpose of this review is to investigate the use of digital health technologies and/or digital therapeutics (DTx) products in the treatment of substance use disorders (SUDs) in the general population and among criminal justice-involved individuals.

Recent findings: Despite an expanding evidence base, only three SUD DTxs have received federal regulatory approval. Across studies, DTx products have proven successful in engaging patients in SUD treatment and reducing healthcare costs and resource utilizations. Findings for emerging SUD DTx products show similar results. Still, there is a paucity of evidence regarding the use of digital health technologies and/or DTx among criminal justice populations.

Summary: DTxs have proven effective for treating multiple SUD types (e.g., nicotine and opioids) among the general population. DTx shows similar promise among justice-involved populations, but additional efficacy and implementation research is needed to address barriers such as cost, cultural resistance, and infrastructure.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

在刑事司法环境中使用数字健康和数字治疗治疗SUD：综述。

综述目的：本综述的目的是调查数字健康技术和/或数字治疗（DTx）产品在普通人群和涉及刑事司法的个人中治疗物质使用障碍（sud）的使用情况。最近的研究发现：尽管证据基础不断扩大，但只有三种SUD DTxs获得了联邦监管机构的批准。多项研究证明，DTx产品在吸引患者参与SUD治疗、降低医疗成本和资源利用方面取得了成功。对新兴的SUD DTx产品的研究结果也显示出类似的结果。尽管如此，关于刑事司法人员使用数字卫生技术和/或DTx的证据仍然缺乏。摘要：DTxs已被证明对治疗普通人群中的多种SUD类型（如尼古丁和阿片类药物）有效。DTx在参与司法的人群中显示出类似的前景，但需要进行更多的功效和实施研究，以解决成本、文化阻力和基础设施等障碍。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Current Addiction Reports Psychology-Clinical Psychology

CiteScore

6.60

自引率

4.70%

发文量

期刊介绍： This journal focuses on the prevention, assessment and diagnosis, and treatment of addiction. Designed for physicians and other mental health professionals who need to keep up-to-date with the latest research, Current Addiction Reports offers expert reviews on the most recent and important research in addiction. We accomplish this by appointing leaders in the field to serve as Section Editors in key subject areas and disciplines, such asAlcoholTobaccoStimulants, cannabis, and club drugsBehavioral addictionsGender disparities in addictionComorbid psychiatric disorders and addictionSubstance abuse disorders and HIVSection Editors, in turn, select the most pressing topics as well as experts to evaluate the latest research, report on any controversial discoveries or hypotheses of interest, and ultimately bring readers up-to-date on the topic. Articles represent interdisciplinary endeavors with research from fields such as psychiatry, psychology, pharmacology, epidemiology, and neuroscience.Additionally, an international Editorial Board—representing a range of disciplines within addiction medicine—ensures that the journal content includes current, emerging research and suggests articles of special interest to their country or region.